Unitedhealth Group — Income Statement, Cash Flows & Balance Sheet
Is UnitedHealth Group profitable?
Revenue grew strongly, but profitability collapsed due to surging medical costs and large restructuring charges.
| Metric | 2024 | 2025 | Change |
|---|---|---|---|
| Total revenues | $400.3B | $447.6B | +$47.3B (+11.8%) |
| Medical costs | $264.2B | $314.0B | +$49.8B (+18.9%) |
| Medical cost ratio (medical costs ÷ premiums) | 85.5% | 89.2% | +3.7 pts |
| Earnings from operations | $32.3B | $19.0B | -$13.3B (-41.3%) |
| Net earnings attributable to UHG shareholders | $14.4B | $12.1B | -$2.3B (-16.4%) |
| Diluted EPS | $15.51 | $13.23 | -$2.28 (-14.7%) |
Revenue growth was solid, but medical costs grew nearly twice as fast as premiums, squeezing margins significantly. A further drag came from roughly $2.5 billion in fourth-quarter restructuring charges — covering real estate, workforce reductions, and a loss-contract reserve for certain value-based care businesses — that are one-time in nature and distort the underlying run rate. Stripping those out, the business is still generating meaningful profit, but the core insurance margin pressure is real and ongoing.
A large loss on asset sales in 2024 and a gain/loss mix in 2025 also distort year-over-year comparisons.
| Item | 2024 | 2025 | Change |
|---|---|---|---|
| Loss on sale of subsidiary / held-for-sale | $(8.3B) | $(0.3B) | +$8.0B improvement |
| Effective tax rate | 24.1% | 12.9% | -11.2 pts |
The 2024 figure was dominated by a $7.1 billion loss on the sale of UnitedHealth's Brazil operations. The 2025 effective tax rate dropped sharply, partly because portfolio divestiture gains carry favorable tax treatment — meaning reported net income in both years is influenced heavily by non-recurring items on both the revenue and tax lines.
Where does UnitedHealth Group's revenue come from?
UnitedHealthcare remains the revenue engine, but Optum Health swung from a profitable contributor to a loss-maker.
| Segment | 2024 Operating Earnings | 2025 Operating Earnings | Change |
|---|---|---|---|
| UnitedHealthcare | $15.6B | $9.4B | -$6.2B (-39.7%) |
| Optum Health | $7.8B | $(0.3B) | -$8.1B (swing to loss) |
| Optum Insight | $3.1B | $2.6B | -$0.5B (-15.3%) |
| Optum Rx | $5.8B | $7.2B | +$1.4B (+23.3%) |
UnitedHealthcare's profitability declined as higher medical costs outpaced premium growth. Optum Health flipped to an operating loss, driven by the $1.7 billion restructuring hit to that segment plus underlying pressure in its value-based care business. Optum Rx was the standout, growing earnings by nearly a quarter as its pharmacy revenues rose from $133B to $155B. Optum Insight was broadly stable despite absorbing cyberattack-related loan reserves.
Does UnitedHealth Group generate cash?
The business still generates substantial operating cash, though the amount declined noticeably.
| Cash Flow Item | 2024 | 2025 | Change |
|---|---|---|---|
| Cash from operations | $24.2B | $19.7B | -$4.5B (-18.6%) |
| Capital expenditures | $(3.5B) | $(3.6B) | -$0.1B |
| Free cash flow (approx.) | $20.7B | $16.1B | -$4.6B (-22.2%) |
| Dividends paid | $(7.5B) | $(7.9B) | -$0.4B |
| Share repurchases | $(9.0B) | $(5.5B) | +$3.5B reduction |
Operating cash flow declined but remains well above $15 billion, and the company continued to pay a growing dividend. Share buybacks slowed considerably — a sign management is conserving capital amid margin pressure. The company returned a total of roughly $13.4 billion to shareholders through dividends and buybacks in 2025.
How strong is UnitedHealth Group's balance sheet?
Debt is large but long-dated, and the company holds ample liquidity to meet near-term obligations.
| Item | 2024 | 2025 | Change |
|---|---|---|---|
| Cash and short-term investments | $29.1B | $28.1B | -$1.0B |
| Total debt (short- and long-term) | $76.2B | $77.7B | +$1.5B |
| Current debt maturities | $4.5B | $6.1B | +$1.5B |
| Medical costs payable | $34.2B | $39.3B | +$5.1B (+14.9%) |
The debt load is substantial in absolute terms, but it is mostly long-dated — only about $6B is due within twelve months, against nearly $28B in liquid assets plus three undrawn revolving credit facilities totalling $21B. The sharp rise in medical costs payable reflects both enrollment growth and the lag in processing claims — this is a normal operating liability, not a sign of financial distress. Goodwill of $110B (roughly a third of total assets) is worth watching, as any impairment could hit book value, though no impairments were recorded in 2025.